SCHEMBL1875458

SCHEMBL1875458

Oc1ccc2cc[nH]c2c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.42
RIPK1 Q13546 1/20 0.42
TYR P14679 1/20 0.40
AHR P35869 1/20 0.40
KEAP1 Q14145 1/20 0.39
PDPK1 O15530 1/20 0.38
PTPN22 Q9Y2R2 1/20 0.38
PTPRC P08575 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPRB P23467 1/20 0.36
PTPRE P23469 1/20 0.36
PTPN6 P29350 1/20 0.36
ALOX15 P16050 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
USP2 O75604 1/20 0.35
GAA P10253 1/20 0.35
RAD51 Q06609 1/20 0.35
PRKACA P17612 3/20 0.35
PRKACG P22612 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25079005 0.77 TNF (0.39) TNFRIPK1TYRAHRKEAP1
SCHEMBL29488158 0.77 TNF (0.39) TNFRIPK1TYRAHRKEAP1
SCHEMBL8055277 0.77 TNF (0.39) TNFRIPK1TYRAHRKEAP1
SCHEMBL1374474 0.76 TNF (0.54) TNFRIPK1TYRAHRKEAP1
SCHEMBL29591462 0.76 TNF (0.54) TNFRIPK1TYRAHRKEAP1
SCHEMBL9316145 0.74 GAA (0.39) TNFRIPK1TYRAHRKEAP1
SCHEMBL4624602 0.74 PDPK1 (0.35) TNFRIPK1TYRAHRKEAP1
SCHEMBL17087492 0.73 ERN1 (0.47) TNFRIPK1KEAP1PDPK1BACE1
SCHEMBL9315426 0.73 MCL1 (0.42) TNFRIPK1ALOX15BRD4BACE1
SCHEMBL1880644 0.73 CA1 (0.42) TNFRIPK1TYRAHRKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103517703-B Stain and application thereof 天野酶制品株式会社 2016-11-09 CN claimed
EP-2623093-B1 DYE FOR KERATIN FIBERS USING BILIRUBIN OXIDASE AND INDOLE DERIVATIVES AMANO ENZYME INC (JP) 2016-05-25 EP claimed
CN-103998016-B Employ the dyeing of the keratin fiber of indole analog AMANO ENZYME INC. (JP) 2015-09-16 CN claimed
US-20140359950-A1 DYEING OF KERATIN FIBERS USING INDOLE ANALOGUE AMANO ENZYME INC. (JP) 2014-12-11 US claimed
WO-2011073941-A1 USE OF A POLYMER AS AN ANTIOXIDANT AGENT L'OREAL (FR) 2011-06-23 WO claimed
US-7704285-B2 Composition for coloring a keratin material, comprising at least two components, and coloring processes L'OREAL S.A. (FR) 2010-04-27 US claimed
US-20100005599-A1 COMPOSITION FOR COLORING A KERATIN MATERIAL, COMPRISING AT LEAST TWO COMPONENTS, AND COLORING PROCESSES PRUCHE FRANCIS 2010-01-14 US claimed
WO-2009010684-A2 PROCESS FOR DYEING HUMAN KERATIN MATERIALS USING AN ORTHO-DIPHENOL AND DEHYDROASCORBIC ACID OR A MONOMERIC, POLYMERIC OR ISOMERIC DERIVATIVE THEREOF L'OREAL (FR) 2009-01-22 WO claimed
EP-1405627-B1 Antipenetrating hair pretreatment composition based on polyethelenoxide polymer(s) and process using said composition for limiting skin penetration by colourants OREAL (FR) 2008-04-30 EP claimed
US-7270685-B2 Coloring composition for keratin fibres comprising a system limiting the transcutaneous passage of an oxidation dye L'OREAL (FR) 2007-09-18 US claimed
EP-1348421-A2 A method of thickening and styling human keratinous fibres using a particular catalytic system L'OREAL (FR) 2003-10-01 EP claimed
US-20030163878-A1 Dyeing composition, method for obtaining the same and use for colouring the skin and/or keratinous fibres L'OREAL (FR) 2003-09-04 US claimed
US-20030103917-A1 Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres L'OREAL (FR) 2003-06-05 US claimed
WO-2002076422-A1 USE OF A MIXTURE COMPRISING MN(II) AND/OR ZN(II) WITH A HYDROGENOCARBONATE AND AT LEAST AN ORTHODIPHENOL, AS AGENT REDUCING ADHESION OF MICRO-ORGANISMS L'OREAL (FR) 2002-10-03 WO claimed
US-20020124330-A1 Coloration composition, process for obtaining the same and its use for the coloration of keratin fibres L'OREAL (FR) 2002-09-12 US claimed
EP-1229892-A1 DYEING COMPOSITION, METHOD FOR OBTAINING SAME AND USE FOR COLOURING THE SKIN AND/OR KERATINOUS FIBRES L'OREAL (FR) 2002-08-14 EP claimed
EP-1229890-A1 DYEING COMPOSITION PROMOTING NATURAL PIGMENTATION, METHOD FOR OBTAINING SAME AND USE FOR COLOURING THE SKIN AND/OR KERATINOUS FIBRES L'OREAL (FR) 2002-08-14 EP claimed
EP-1210931-A1 Keratinic fibres dyeing composition L'OREAL (FR) 2002-06-05 EP claimed
WO-2002030371-A1 DYEING COMPOSITION PROMOTING NATURAL PIGMENTATION, METHOD FOR OBTAINING SAME AND USE FOR COLOURING THE SKIN AND/OR KERATINOUS FIBRES L"OREAL (FR) 2002-04-18 WO claimed
WO-2002030375-A1 DYEING COMPOSITION, METHOD FOR OBTAINING SAME AND USE FOR COLOURING THE SKIN AND/OR KERATINOUS FIBRES L"OREAL (FR) 2002-04-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030103917-A1 Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres TYR, KRT18, POLR1C TNF 3893/4885RIPK1 4760/4885TYR 1/4885
US-20030163878-A1 Dyeing composition, method for obtaining the same and use for colouring the skin and/or keratinous fibres KRT18, HAO2, TYR TNF 3457/4885RIPK1 4513/4885TYR 3/4885
US-20100005599-A1 COMPOSITION FOR COLORING A KERATIN MATERIAL, COMPRISING AT LEAST TWO COMPONENTS, AND COLORING PROCESSES KRT18, KATNA1, MARK1 TNF 4748/4885RIPK1 4366/4885TYR 12/4885
US-20020124330-A1 Coloration composition, process for obtaining the same and its use for the coloration of keratin fibres KRT18, TYR, OAT TNF 4715/4885RIPK1 4752/4885TYR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.